Correlation Between Polyplex Public and Lion Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Polyplex Public and Lion Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polyplex Public and Lion Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Polyplex Public and Lion Biotechnologies, you can compare the effects of market volatilities on Polyplex Public and Lion Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polyplex Public with a short position of Lion Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polyplex Public and Lion Biotechnologies.

Diversification Opportunities for Polyplex Public and Lion Biotechnologies

-0.54

Correlation Coefficient

Polyplex Public  Lion Biotechnologies

Excellent diversification

The 3 months correlation between Polyplex and Lion is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Polyplex Public and Lion Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lion Biotechnologies and Polyplex Public is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polyplex Public are associated (or correlated) with Lion Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lion Biotechnologies has no effect on the direction of Polyplex Public i.e., Polyplex Public and Lion Biotechnologies go up and down completely randomly.

Pair Corralation between Polyplex Public and Lion Biotechnologies

Assuming the 90 days horizon Polyplex Public is expected to under-perform the Lion Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Polyplex Public is 1.67 times less risky than Lion Biotechnologies. The stock trades about -0.35 of its potential returns per unit of risk. The Lion Biotechnologies is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  795.00  in Lion Biotechnologies on October 6, 2024 and sell it today you would lose (43.00) from holding Lion Biotechnologies or give up 5.41% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Polyplex Public  vs.  Lion Biotechnologies

Polyplex Public

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Polyplex Public are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Polyplex Public reported solid returns over the last few months and may actually be approaching a breakup point.

Lion Biotechnologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lion Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Polyplex Public and Lion Biotechnologies

The main advantage of trading using opposite Polyplex Public and Lion Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polyplex Public position performs unexpectedly, Lion Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lion Biotechnologies will offset losses from the drop in Lion Biotechnologies' long position.

The idea behind Polyplex Public and Lion Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.